Immune modulation by mesenchymal stem cells (Q36456612)

14 August 2017

1 reference

title

Immune modulation by mesenchymal stem cells. (English)

1 reference

14 August 2017

mesenchymal stem cell

1 reference

Ida Rasmusson

1

1 reference

PubMed ID

16631737

14 August 2017

language of work or name

English

0 references

publication date

24 April 2006

1 reference

Experimental Cell Research

14 August 2017

1 reference

14 August 2017

312

1 reference

14 August 2017

2169-2179

1 reference

14 August 2017

12

1 reference

Functional studies of mesenchymal stem cells derived from adult human adipose tissue

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells can be differentiated into endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Adult bone marrow stromal cells differentiate into neural cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Rapid neural differentiation of human cord blood-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells modulate allogeneic immune cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunology. A perfect mismatch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

The profile of gene expression of human marrow mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Active movement of T cells away from a chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

RANK-L and RANK: T cells, bone loss, and mammalian evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Inhibition of T cell proliferation by macrophage tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

T cell proliferation is blocked by indoleamine 2,3-dioxygenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

T cell apoptosis by kynurenines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Mesenchymal stem cells induce apoptosis of activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Graft-versus-host disease in dog and man: the Seattle experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

An essential role for thymic mesenchyme in early T cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunoregulatory molecules during pregnancy and at birth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Thecal cell-granulosa cell interactions involve a positive feedback loop among keratinocyte growth factor, hepatocyte growth factor, and Kit ligand during ovarian follicular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Prevention of allogeneic fetal rejection by tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Longitudinal study of tryptophan degradation during and after pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

Immunologic properties of human fetal mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.03.019

10.1016/J.YEXCR.2006.03.019

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16631737